Latest Free Cash Flow News

Brazilian Rare Earths has strengthened the development case for its Brazilian rare earths portfolio, reporting high-grade Monte Alto drilling, a new Sulista discovery and first concentrate production at Camaçari. The company ended September with A$121.8 million in cash and no borrowings, although its headline US$6.0 billion project valuation remains based on a preliminary study with substantial inferred resources.

Aureka is approaching a decisive shareholder vote on its proposed acquisition of the Fiddlers Creek mine and Wedderburn mill, after raising $7.25 million and ending September with $6.993 million in cash. Exploration results at Irvine and Comstock add further upside, but the company’s transition from explorer to producer is not yet complete.

Bellevue Gold has kept FY27 production and cost guidance intact despite a slower-than-expected mining contractor ramp-up that reduced September-quarter output to 35,585 ounces. The company also cut forward sales commitments to 57.5koz, increasing its future exposure to spot gold prices while capital spending weighed on free cash flow.

Australian Vintage has returned to positive operating cash flow, but its FY26 statutory loss widened sharply after a $27 million inventory write-down and deferred tax charge. The wine group is betting that Poco Vino growth, further restructuring and lower stock levels can convert the cash improvement into debt reduction in FY27.

Aura Energy’s Tiris uranium project has emerged from its bankable feasibility study with a US$500.3 million post-tax NPV and a target to produce by the end of 2028. The economics are substantial, but the funding package is not secured and nearly one-third of the mine plan relies on Inferred Resources.

Alcoa delivered a $483 million third-quarter profit and its sixth consecutive quarter of higher aluminium production, while South32 shareholders approved the company’s planned upstream asset acquisition. The deal remains targeted for completion in the first half of 2027, with $2.6 billion of acquisition financing now raised.

Alfabs has carried its cash-generation reset into FY27, producing $2.4 million of free cash flow and cutting net debt to $35.5 million in the September quarter. Mining hire rates strengthened, but weak engineering demand and unfinished debt refinancing still stand between the company and a dividend restart.

Medical Developments International CEO Brent MacGregor is stepping down after six years, with CFO Anita James taking over as interim CEO from 15 October. The board has begun searching for a permanent successor as MacGregor prepares to return to North America.

Airtasker’s Australian marketplace reached a record $57.3 million in first-quarter GMV, while paid subscribers more than doubled in three months. The company reaffirmed FY27 guidance as international growth continued, though seasonal weakness is expected in the UK and US.

Orora says strong Cans growth is no longer enough to offset weaker Saverglass earnings, with Group EBIT expected to decline in FY27. The company is targeting more than €30 million in Glass EBIT improvement by FY30 after a €449.7 million non-cash impairment.

Stavely Minerals is testing smaller and potentially easier-to-fund development routes for Thursday’s Gossan after a large open-pit study delivered strong economics but demanded substantial upfront capital. The alternatives could reduce capital intensity, although the company expects they may produce lower NPVs.

Medical Developments International returned to EBIT profitability in FY26 as Penthrox volumes strengthened across Australian hospitals and Europe. The company now faces the less glamorous test of converting regulatory progress into repeatable demand while absorbing weaker Respiratory sales and new amortisation costs.